These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 27297459)

  • 1. Recombinant biologic products versus nutraceuticals from plants - a regulatory choice?
    Drake PM; Szeto TH; Paul MJ; Teh AY; Ma JK
    Br J Clin Pharmacol; 2017 Jan; 83(1):82-87. PubMed ID: 27297459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Commercial aspects of pharmaceutical protein production in plants.
    Fischer R; Schillberg S; Buyel JF; Twyman RM
    Curr Pharm Des; 2013; 19(31):5471-7. PubMed ID: 23394566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target product selection - where can Molecular Pharming make the difference?
    Paul MJ; Teh AY; Twyman RM; Ma JK
    Curr Pharm Des; 2013; 19(31):5478-85. PubMed ID: 23394563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant plant-derived pharmaceutical proteins: current technical and economic bottlenecks.
    Sabalza M; Christou P; Capell T
    Biotechnol Lett; 2014 Dec; 36(12):2367-79. PubMed ID: 25048244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conference scene: molecular pharming: manufacturing medicines in plants.
    Lössl AG; Clarke JL
    Immunotherapy; 2013 Jan; 5(1):9-12. PubMed ID: 23256793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in plant molecular farming.
    Obembe OO; Popoola JO; Leelavathi S; Reddy SV
    Biotechnol Adv; 2011; 29(2):210-22. PubMed ID: 21115109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GMP issues for recombinant plant-derived pharmaceutical proteins.
    Fischer R; Schillberg S; Hellwig S; Twyman RM; Drossard J
    Biotechnol Adv; 2012; 30(2):434-9. PubMed ID: 21856403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk assessment and regulation of molecular farming - a comparison between Europe and US.
    Sparrow P; Broer I; Hood EE; Eversole K; Hartung F; Schiemann J
    Curr Pharm Des; 2013; 19(31):5513-30. PubMed ID: 23394565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Critical Review of the Concept of Transgenic Plants: Insights into Pharmaceutical Biotechnology and Molecular Farming.
    Abiri R; Valdiani A; Maziah M; Shaharuddin NA; Sahebi M; Yusof ZN; Atabaki N; Talei D
    Curr Issues Mol Biol; 2016; 18():21-42. PubMed ID: 25944541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plant molecular farming for the production of valuable proteins - Critical evaluation of achievements and future challenges.
    Schillberg S; Finnern R
    J Plant Physiol; 2021; 258-259():153359. PubMed ID: 33460995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current state-of-the-art in plant-based antibody production systems.
    Donini M; Marusic C
    Biotechnol Lett; 2019 Mar; 41(3):335-346. PubMed ID: 30684155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing the yield of recombinant pharmaceutical proteins in plants.
    Twyman RM; Schillberg S; Fischer R
    Curr Pharm Des; 2013; 19(31):5486-94. PubMed ID: 23394567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plant molecular farming: systems and products.
    Horn ME; Woodard SL; Howard JA
    Plant Cell Rep; 2004 May; 22(10):711-20. PubMed ID: 14997337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biopharmaceuticals derived from genetically modified plants.
    Goldstein DA; Thomas JA
    QJM; 2004 Nov; 97(11):705-16. PubMed ID: 15496527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The regulation of biologic products derived from bioengineered plants.
    Stein KE; Webber KO
    Curr Opin Biotechnol; 2001 Jun; 12(3):308-11. PubMed ID: 11404111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the verge of the market - Plant factories for the automated and standardized production of biopharmaceuticals.
    Huebbers JW; Buyel JF
    Biotechnol Adv; 2021; 46():107681. PubMed ID: 33326816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Realising the value of plant molecular pharming to benefit the poor in developing countries and emerging economies.
    Ma JK; Christou P; Chikwamba R; Haydon H; Paul M; Ferrer MP; Ramalingam S; Rech E; Rybicki E; Wigdorovitz A; Yang DC; Thangaraj H
    Plant Biotechnol J; 2013 Dec; 11(9):1029-33. PubMed ID: 24119183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of a regulatory framework for pharmaceuticals derived from genetically modified plants.
    Spök A; Twyman RM; Fischer R; Ma JK; Sparrow PA
    Trends Biotechnol; 2008 Sep; 26(9):506-17. PubMed ID: 18676047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of Molecular Farming Products.
    Hundleby PAC; D'Aoust MA; Finkle C; Atkins J; Twyman RM
    Methods Mol Biol; 2022; 2480():313-333. PubMed ID: 35616870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory approval and a first-in-human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants.
    Ma JK; Drossard J; Lewis D; Altmann F; Boyle J; Christou P; Cole T; Dale P; van Dolleweerd CJ; Isitt V; Katinger D; Lobedan M; Mertens H; Paul MJ; Rademacher T; Sack M; Hundleby PA; Stiegler G; Stoger E; Twyman RM; Vcelar B; Fischer R
    Plant Biotechnol J; 2015 Oct; 13(8):1106-20. PubMed ID: 26147010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.